Skip to main content
Erschienen in: Journal of General Internal Medicine 3/2019

22.10.2018 | Concise Research Report

Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings

verfasst von: Sudha R. Raman, PhD, Jeffrey S. Brown, PhD, Lesley H. Curtis, PhD, Kevin Haynes, MSCE, PharmD, James Marshall, MPH, Pamala A. Pawloski, PharmD, Richard Platt, MD, MSc

Erschienen in: Journal of General Internal Medicine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

Routinely collected electronic health data about cancer screening and follow-up would be helpful adjuncts for assessing guideline adherence in real-world populations. We compared the use of insurance claims data to other sources to describe (1) abnormal colorectal cancer, breast cancer, and cervical cancer screening results and (2) follow-up after abnormal cancer screening results. …
Literatur
1.
Zurück zum Zitat Robb MA, Racoosin JA, Sherman RE, et al. The US Food and Drug Administration’s Sentinel Initiative: expanding the horizons of medical product safety. Pharmacoepidemiol Drug Saf 2012;21(Suppl 1):9–11.CrossRef Robb MA, Racoosin JA, Sherman RE, et al. The US Food and Drug Administration’s Sentinel Initiative: expanding the horizons of medical product safety. Pharmacoepidemiol Drug Saf 2012;21(Suppl 1):9–11.CrossRef
2.
Zurück zum Zitat Ball R, Robb M, Anderson SA, Dal Pan G. The FDA’s Sentinel Initiative: A comprehensive approach to medical product surveillance. Clin Pharmacol Ther 2016;99:265–8.CrossRef Ball R, Robb M, Anderson SA, Dal Pan G. The FDA’s Sentinel Initiative: A comprehensive approach to medical product surveillance. Clin Pharmacol Ther 2016;99:265–8.CrossRef
6.
Zurück zum Zitat Tosteson AN, Beaber EF, Tiro J, et al. Variation in screening abnormality rates and follow-up of breast, cervical and colorectal cancer screening within the PROSPR Consortium. J Gen Intern Med 2016;31:372–9.CrossRef Tosteson AN, Beaber EF, Tiro J, et al. Variation in screening abnormality rates and follow-up of breast, cervical and colorectal cancer screening within the PROSPR Consortium. J Gen Intern Med 2016;31:372–9.CrossRef
Metadaten
Titel
Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings
verfasst von
Sudha R. Raman, PhD
Jeffrey S. Brown, PhD
Lesley H. Curtis, PhD
Kevin Haynes, MSCE, PharmD
James Marshall, MPH
Pamala A. Pawloski, PharmD
Richard Platt, MD, MSc
Publikationsdatum
22.10.2018
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 3/2019
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4697-y

Weitere Artikel der Ausgabe 3/2019

Journal of General Internal Medicine 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.